Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)
Cellebrite DI has reported Total Non-Current Liabilities over the past 6 years, most recently at $84.9 million for Q4 2025.
- Quarterly results put Total Non-Current Liabilities at $84.9 million for Q4 2025, up 43.75% from a year ago — trailing twelve months through Dec 2025 was $84.9 million (up 43.75% YoY), and the annual figure for FY2025 was $84.9 million, up 43.75%.
- Total Non-Current Liabilities for Q4 2025 was $84.9 million at Cellebrite DI, up from $59.0 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for CLBT hit a ceiling of $244.8 million in Q4 2023 and a floor of $59.0 million in Q4 2024.
- Median Total Non-Current Liabilities over the past 5 years was $121.7 million (2022), compared with a mean of $147.4 million.
- Biggest five-year swings in Total Non-Current Liabilities: soared 466.45% in 2021 and later plummeted 75.89% in 2024.
- Cellebrite DI's Total Non-Current Liabilities stood at $226.6 million in 2021, then crashed by 46.3% to $121.7 million in 2022, then surged by 101.27% to $244.8 million in 2023, then plummeted by 75.89% to $59.0 million in 2024, then skyrocketed by 43.75% to $84.9 million in 2025.
- The last three reported values for Total Non-Current Liabilities were $84.9 million (Q4 2025), $59.0 million (Q4 2024), and $244.8 million (Q4 2023) per Business Quant data.